← Evidence map

ArticleBiomedicines2026

The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response?

Maria Komisarz-Calik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41595768